Companies
Auxilium Biotechnologies
bioprinted kidney and liver tissues in space for the first time, using its own orbital biomanufacturing device, and in February 2026 agreed to supply orbital 3D bioprinting capability aboard the Starlab commercial station.
- Country
- United States
US
Coverage
| CN | EU | US | |
|---|---|---|---|
| cross-sector-intersections | ✓ | ✓ | ✓ |
Regulatorsfdafaa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| In-space organ bioprinting | cross-sector-intersections | High | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.